Breaking News Headlines Today | Ground News

See every side of every news story

Managed Healthcare Executive image

News from Managed Healthcare Executive

Managed Healthcare Executive’s media bias is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

Managed Healthcare Executive’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Managed Healthcare Executive

Where is Managed Healthcare Executive located?Managed Healthcare Executive's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Managed Healthcare Executive News

FDA Reverses Decades-Old Warning on Hormone Therapy Products for Menopause — REUTERS / pwu404

FDA · United States

FDA Reverses Decades-Old Warning on Hormone Therapy Products for Menopause

51% Center coverage: 203 sources

FDA removes black box warning on hormone therapy, reflecting new science on menopause, heart health, and evolving views on women’s care.See the Story

FDA Lifts Major Warnings on Hormone Replacement Therapy

Coronavirus · United States

FDA Lifts Major Warnings on Hormone Replacement Therapy

Coverage: 2 sources

The U.S. Food and Drug Administration (FDA) is eliminating the prominent "black box" warnings on many hormone replacement therapy (HRT) medications, signaling a major shift in how the treatment is viewed for menopausal women.See the Story

Key HER2-Positive Breast Cancer Therapy Gets Its First Biosimilar

Cancer · United States

Key HER2-Positive Breast Cancer Therapy Gets Its First Biosimilar

100% Center coverage: 1 sources

(MedPage Today) -- The FDA approved pertuzumab-dpzb (Poherdy) as the first biosimilar for its reference product Perjeta, a monoclonal antibody commonly used in standard regimens for HER2-positive breast cancer. FDA granted the targeted agent an...See the Story

Breaking News Topics Related to Managed Healthcare Executive